MYmAb Biologics is a trusted tissue microarray company (https://www.mymab.com.my/) providing high-quality human tissue microarrays (TMAs) for both clinical and research applications. With a strong commitment to ethical sourcing, rigorous quality standards, and reliable global distribution, MYmAb Biologics supports researchers worldwide in advancing translational research and oncology studies using clinically relevant human tissue samples.
NBiOSHOWCASE 2025 concluded successfully last week at the Borneo Convention Centre Kuching (BCCK), Sarawak, bringing together key stakeholders across Malaysia’s life sciences and biotechnology ecosystem. The event marked a significant moment for MYmAb Biologics, which was honoured to have officially obtained BioNexus Status earlier this year and invited to the BioNexus Status Certificate Presentation Ceremony to receive the certification.
The BioNexus Status recognition represents an important milestone for MYmAb Biologics as an innovative Malaysian biotechnology company contributing to the nation’s life sciences growth. It reflects the company’s commitment to scientific excellence, innovation, and its role in strengthening Malaysia’s position in the global biotechnology value chain.
In addition to the certificate presentation, MYmAb Biologics also participated in NBiOSHOWCASE 2025 as an exhibitor, showcasing its ArrayZeal Tissue Microarrays (TMAs). Through ArrayZeal, MYmAb Biologics brings Southeast Asian tumour data into the global research landscape, enabling researchers to generate insights that better reflect real-world population diversity and support more equitable cancer research outcomes.
Overall, NBiOSHOWCASE 2025 was an impactful and rewarding event for MYmAb Biologics, reinforcing its mission to advance meaningful scientific discoveries through high-quality, ethically sourced tissue microarrays. The company extends its sincere appreciation to Bioeconomy Corporation for organising the event and supporting the growth of Malaysia’s biotechnology ecosystem.
To learn more about MYmAb Biologics and its tissue microarray solutions, visit the MYmAb Biologics website.
This news article is provided and written by Pillars Media (https://pillarsmedia.my/).